Vasopressin Deficiency

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Tonix Pharmaceuticals
Tonix PharmaceuticalsBERKELEY HEIGHTS, NJ
1 program
1
Intranasal OxytocinPhase 11 trial
Active Trials
NCT04789148RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Tonix PharmaceuticalsIntranasal Oxytocin

Clinical Trials (1)

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

Start: Sep 2025Est. completion: Jun 2026
Phase 1Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space